Image from Chest CT Scan Module courtesy of RADLogics
November 24, 2015 — At the Radiological Society of North America’s (RSNA) 2015 annual meeting, RADLogics will showcase its machine-learning image analysis solution for addressing the massive increase in the volume and complexity of medical imaging data. AlphaPoint performs like the ideal Virtual Resident—providing smart, meticulous and fast detection and characterization of findings. Providers upload imaging data to cloud-based AlphaPoint; findings are sent back to the radiologists within minutes of scan completion, enabling them to focus their time on diagnosis. AlphaPoint information flows directly into popular reporting systems, like the Nuance PowerScribe360, and into any picture archiving and communication system (PACS).
The AlphaPoint technology is featured at the RSNA Centennial Showcase on the future of radiology.
RADLogics will also demonstrate its lung cancer screening app, one part of the company’s Chest CT (Computed Tomography) Scan Module. This demo showcases:
- Accurate detection and characterization of lung nodules in compliance with the American College of Radiology’s (ACR) Lung CT Screening Reporting and Data System (Lung-RADS) protocol;
- Integration with Nuance PowerScribe 360, showing findings (including key images) flowed into the Nuance reporting system; and
- Integration with the AspenLung patient management system from MRS, ensuring radiologists follow all of the ACR recommended steps for a lung cancer screening program, from assessment through follow-up
RADLogics will also preview work-in-progress apps for AlphaPoint, including its Head/Neck CT Module and X-ray Module.
"AlphaPoint saves our radiologists reading time, and improves accuracy,” said Irwin Grossman, M.D., medical director of Grossman Imaging Centers, Ventura, Calif., who have been using AlphaPoint with the Chest CT Scan Module for the past year. “Using the software also provides an overall increased sense of confidence as if another ‘pair of eyes’ looked at the scan and made sure we didn't miss anything important."
The AlphaPoint platform and Chest CT Scan Module are cleared for marketing by the U.S. Food and Drug Administration (FDA).
For more information: www.radlogics.com
July 30, 2024 
